Xinyang Hu

6.4k total citations · 2 hit papers
94 papers, 3.9k citations indexed

About

Xinyang Hu is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Xinyang Hu has authored 94 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 29 papers in Surgery and 22 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Xinyang Hu's work include Mesenchymal stem cell research (20 papers), Coronary Interventions and Diagnostics (13 papers) and Tissue Engineering and Regenerative Medicine (12 papers). Xinyang Hu is often cited by papers focused on Mesenchymal stem cell research (20 papers), Coronary Interventions and Diagnostics (13 papers) and Tissue Engineering and Regenerative Medicine (12 papers). Xinyang Hu collaborates with scholars based in China, United States and Japan. Xinyang Hu's co-authors include Ling Wei, Hong Yu, Jianan Wang, Jianan Wang, Shan Ping Yu, Jinghai Chen, Rongrong Wu, Zhongyang Lu, Wei Zhu and Jamie L. Fraser and has published in prestigious journals such as Circulation, Nature Communications and Journal of the American College of Cardiology.

In The Last Decade

Xinyang Hu

81 papers receiving 3.9k citations

Hit Papers

Large Cardiac Muscle Patc... 2017 2026 2020 2023 2017 2023 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinyang Hu China 32 1.9k 994 923 856 513 94 3.9k
Masaaki Ii Japan 41 2.7k 1.4× 1.2k 1.2× 1.0k 1.1× 554 0.6× 229 0.4× 78 5.3k
Thomas Korff Germany 35 2.5k 1.3× 774 0.8× 540 0.6× 577 0.7× 725 1.4× 75 4.8k
Xiaoting Liang China 29 1.8k 1.0× 929 0.9× 1.4k 1.5× 700 0.8× 161 0.3× 79 3.6k
Junjie Yang China 32 2.5k 1.3× 628 0.6× 405 0.4× 978 1.1× 233 0.5× 126 4.1k
Paolo Madeddu United Kingdom 42 3.2k 1.7× 1.6k 1.6× 1.5k 1.6× 1.0k 1.2× 531 1.0× 165 6.4k
Guillem Genové Sweden 27 3.4k 1.8× 697 0.7× 759 0.8× 868 1.0× 526 1.0× 42 7.5k
Raphaël Guzman Switzerland 45 1.5k 0.8× 1.1k 1.1× 1.2k 1.3× 290 0.3× 549 1.1× 288 7.2k
Lucio Barile Italy 33 4.0k 2.1× 1.9k 1.9× 659 0.7× 1.6k 1.8× 388 0.8× 100 5.5k
Michael Januszyk United States 39 1.7k 0.9× 1.4k 1.4× 1.3k 1.4× 431 0.5× 559 1.1× 115 6.2k
Corey K. Goldman United States 21 2.0k 1.1× 1.1k 1.1× 696 0.8× 537 0.6× 164 0.3× 35 3.5k

Countries citing papers authored by Xinyang Hu

Since Specialization
Citations

This map shows the geographic impact of Xinyang Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyang Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyang Hu more than expected).

Fields of papers citing papers by Xinyang Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyang Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyang Hu. The network helps show where Xinyang Hu may publish in the future.

Co-authorship network of co-authors of Xinyang Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyang Hu. A scholar is included among the top collaborators of Xinyang Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyang Hu. Xinyang Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Lingfeng, Shanshan Dai, Fan Yu, et al.. (2025). Cardiomyocyte‐Enriched USP20 Ameliorates Pathological Cardiac Hypertrophy by Targeting STAT3 Deubiquitination. Advanced Science. 12(23). e2416478–e2416478.
3.
Li, Boran, Xinyi Wang, Xiao Jiang, et al.. (2025). Cholesterol sensing by the SCAP–FAM134B complex regulates ER-phagy and STING innate immunity. Nature Cell Biology. 27(10). 1739–1756.
4.
Yu, Fan, Guo‐Ping Shi, Lingfeng Zhong, et al.. (2025). Cardiomyocyte lncRNA Cpat maintains cardiac homeostasis and mitochondria function by targeting citrate synthase acetylation. Nature Communications. 16(1). 9022–9022.
5.
He, Mengying, Tian Liu, Cansheng Zhu, et al.. (2025). Cardioprotective role of RBFox1 in myocardial infarction-induced heart failure. Cardiovascular Research. 121(16). 2534–2548.
6.
Li, Xinyi, Jiarong Wang, Jiarong Wang, et al.. (2024). Non-swelling polyelectrolyte complex hydrogels with tissue-matchable mechanical properties for versatile wet wound closure. Composites Part B Engineering. 279. 111456–111456. 9 indexed citations
7.
Chen, Yiduo, Jiarong Wang, Jiarong Wang, et al.. (2024). Comparison study of surface-initiated hydrogel coatings with distinct side-chains for improving biocompatibility of polymeric heart valves. Biomaterials Science. 12(10). 2717–2729. 4 indexed citations
8.
He, Jialin, Lei Xiong, Chengyu Li, et al.. (2024). Deep learning prediction of ribosome profiling with Translatomer reveals translational regulation and interprets disease variants. Nature Machine Intelligence. 6(11). 1314–1329. 2 indexed citations
9.
Zhang, Feng, Yan Feng, Yang Xu, et al.. (2024). Adapting cytoskeleton-mitochondria patterning with myocyte differentiation by promyogenic PRR33. Cell Death and Differentiation. 32(1). 177–193. 4 indexed citations
10.
Yang, Junjie, Xiaoqing Sun, Kan Wang, et al.. (2023). On-Site Computed Tomography–Derived Fractional Flow Reserve to Guide Management of Patients With Stable Coronary Artery Disease: The TARGET Randomized Trial. Circulation. 147(18). 1369–1381. 53 indexed citations
11.
Hu, Xinyang, Ting Sun, Chaoqun Wang, et al.. (2023). Golgi-protein 73 facilitates vimentin polymerization in hepatocellular carcinoma. International Journal of Biological Sciences. 19(12). 3694–3708. 4 indexed citations
12.
Li, Yi, Zixin Liu, Feng Liang, et al.. (2023). Dynamics of Endothelial Cell Generation and Turnover in Arteries During Homeostasis and Diseases. Circulation. 149(2). 135–154. 17 indexed citations
13.
Zhao, Gangming, Kongming Liang, Chengwei Pan, et al.. (2022). Graph Convolution Based Cross-Network Multiscale Feature Fusion for Deep Vessel Segmentation. IEEE Transactions on Medical Imaging. 42(1). 183–195. 32 indexed citations
14.
Yue, Tao, Rongrong Wu, Changchen Xiao, et al.. (2021). Long noncoding RNA LUCAT1 enhances the survival and therapeutic effects of mesenchymal stromal cells post-myocardial infarction. Molecular Therapy — Nucleic Acids. 27. 412–426. 7 indexed citations
15.
Gao, Feng, Masaharu Kataoka, Ning Liu, et al.. (2019). Therapeutic role of miR-19a/19b in cardiac regeneration and protection from myocardial infarction. Nature Communications. 10(1). 1802–1802. 212 indexed citations
16.
Hu, Mengjiao, Yangyang Liu, Ming Yue, et al.. (2018). Platelet Shp2 negatively regulates thrombus stability under high shear stress. Journal of Thrombosis and Haemostasis. 17(1). 220–231. 10 indexed citations
17.
Gao, Ling, Zachery R. Gregorich, Wuqiang Zhu, et al.. (2017). Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell–Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine. Circulation. 137(16). 1712–1730. 338 indexed citations breakdown →
18.
Wang, Kan, Zhi Jiang, Keith A. Webster, et al.. (2016). Enhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21. Stem Cells Translational Medicine. 6(1). 209–222. 238 indexed citations
19.
Xu, Yinchuan, Xinyang Hu, Lihan Wang, et al.. (2013). Preconditioning via Angiotensin Type 2 Receptor Activation Improves Therapeutic Efficacy of Bone Marrow Mononuclear Cells for Cardiac Repair. PLoS ONE. 8(12). e82997–e82997. 20 indexed citations
20.
Hu, Xinyang. (2012). PLCD1 (phospholipase C, delta 1). Atlas of Genetics and Cytogenetics in Oncology and Haematology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026